Industry Growth Insights published a new data on “Chronic Cough Market”. The research report is titled “Chronic Cough Market research by Types (Oral, Injections, Nasal, Others), By Applications (HospitalPharmacy, OnlinePharmacy, RetailPharmacy), By Players/Companies Novartis AG, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline, Bayer AG, Mylan N.V., Amneal Pharmaceuticals, Inc., Cipla Inc., Reckitt Benckiser Group, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chronic Cough Market Research Report
By Type
Oral, Injections, Nasal, Others
By Application
HospitalPharmacy, OnlinePharmacy, RetailPharmacy
By Companies
Novartis AG, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline, Bayer AG, Mylan N.V., Amneal Pharmaceuticals, Inc., Cipla Inc., Reckitt Benckiser Group, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Chronic Cough Market Report Segments:
The global Chronic Cough market is segmented on the basis of:
Types
Oral, Injections, Nasal, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
HospitalPharmacy, OnlinePharmacy, RetailPharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline
- Bayer AG
- Mylan N.V.
- Amneal Pharmaceuticals, Inc.
- Cipla Inc.
- Reckitt Benckiser Group
- Sun Pharmaceutical Industries Ltd
- Aurobindo Pharma Ltd
Highlights of The Chronic Cough Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injections
- Nasal
- Others
- By Application:
- HospitalPharmacy
- OnlinePharmacy
- RetailPharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chronic Cough Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chronic cough is a persistent cough that lasts for more than two weeks.
Some of the major players in the chronic cough market are Novartis AG, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline, Bayer AG, Mylan N.V., Amneal Pharmaceuticals, Inc., Cipla Inc., Reckitt Benckiser Group, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chronic Cough Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Chronic Cough Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Chronic Cough Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Chronic Cough Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Chronic Cough Market Size & Forecast, 2018-2028 4.5.1 Chronic Cough Market Size and Y-o-Y Growth 4.5.2 Chronic Cough Market Absolute $ Opportunity
Chapter 5 Global Chronic Cough Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chronic Cough Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injections
5.2.3 Nasal
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chronic Cough Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chronic Cough Market Size Forecast by Applications
6.2.1 HospitalPharmacy
6.2.2 OnlinePharmacy
6.2.3 RetailPharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chronic Cough Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chronic Cough Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chronic Cough Analysis and Forecast
9.1 Introduction
9.2 North America Chronic Cough Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chronic Cough Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injections
9.6.3 Nasal
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chronic Cough Market Size Forecast by Applications
9.10.1 HospitalPharmacy
9.10.2 OnlinePharmacy
9.10.3 RetailPharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chronic Cough Analysis and Forecast
10.1 Introduction
10.2 Europe Chronic Cough Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chronic Cough Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injections
10.6.3 Nasal
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chronic Cough Market Size Forecast by Applications
10.10.1 HospitalPharmacy
10.10.2 OnlinePharmacy
10.10.3 RetailPharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chronic Cough Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chronic Cough Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chronic Cough Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injections
11.6.3 Nasal
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chronic Cough Market Size Forecast by Applications
11.10.1 HospitalPharmacy
11.10.2 OnlinePharmacy
11.10.3 RetailPharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chronic Cough Analysis and Forecast
12.1 Introduction
12.2 Latin America Chronic Cough Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chronic Cough Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injections
12.6.3 Nasal
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chronic Cough Market Size Forecast by Applications
12.10.1 HospitalPharmacy
12.10.2 OnlinePharmacy
12.10.3 RetailPharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chronic Cough Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chronic Cough Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chronic Cough Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injections
13.6.3 Nasal
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chronic Cough Market Size Forecast by Applications
13.10.1 HospitalPharmacy
13.10.2 OnlinePharmacy
13.10.3 RetailPharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chronic Cough Market: Competitive Dashboard
14.2 Global Chronic Cough Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis AG
14.3.2 Teva Pharmaceutical Industries Ltd
14.3.3 GlaxoSmithKline
14.3.4 Bayer AG
14.3.5 Mylan N.V.
14.3.6 Amneal Pharmaceuticals, Inc.
14.3.7 Cipla Inc.
14.3.8 Reckitt Benckiser Group
14.3.9 Sun Pharmaceutical Industries Ltd
14.3.10 Aurobindo Pharma Ltd